
Arashdeep Singh🐁🧠🥙
@singharashdeep
Science Communicator
Scientist @Researchdiets
Interests: Vagus, Microbiota, Nutrition, & Obesity
RT/FAV≠Endorsement
Alum: @UCalgary @Penn @UF @MonellSc
ID: 116191997
https://scholar.google.ca/citations?user=O7Ev7xgAAAAJ&hl=en 21-02-2010 14:24:00
2,2K Tweet
1,1K Followers
2,2K Following


Huge thanks to Daily Express for helping amplify the importance of #raredisease research & highlighting our new findings published in Journal of Clinical Investigation ‘Compulsive eating’ could be symptom of rare disorder as new study offers hope express.co.uk/life-style/hea…



Is increased hunger really a primary driver of obesity? In this Letter to the Editor in NEJM, Thorkild Sørensen, Mark Friedman and I question the widespread idea that many people develop obesity because they overeat 👇 1/5 nejm.org/doi/full/10.10… NNF Center for Basic Metabolic Research (CBMR) Monell Center



Most viewed this week from JAMA Psychiatry: Low-dose semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder. ja.ma/4dQ3Kid


🧠Neural Circuit lab Seoul National University invites exceptional postdoc researchers from abroad under the prestigious Brain Pool Fellowship (300-900 million KRW/yr covering salary, airfare, relocation, child education, and insurance support. Please RT🔁!

Identifying GLP-1 receptor therapy as a first-in-class treatment for Bardet-Biedl syndrome— @gdelartigue, Arashdeep Singh🐁🧠🥙 & team Monell Center show treatment with semaglutide reduced eating/weight gain, and improved glucose tolerance and cognitive behavior in a BBS mouse model:


Thank you Professor Tomlinson for such an insightful commentary on our paper in Journal of Clinical Investigation 🙏🏻


🚨Our Missouri Physiological Society Coffee with the Expert series is back this summer! 🚨 Join our first session with Dr. Arashdeep Singh🐁🧠🥙 - a project manager and scientist from Research Diets Inc. on July 10th, 11am-12pm CDT via Zoom! Register here: bit.ly/mophysCoffeewi… American Physiological Society



ICYMI: Identifying GLP-1 receptor therapy as a first-in-class treatment for Bardet-Biedl syndrome— @gdelartigue, Arashdeep Singh🐁🧠🥙 & team Monell Center show treatment with semaglutide reduced eating/weight gain, and improved glucose tolerance and cognitive behavior in a BBS mouse


Very humbled to be invited to speak at Missouri Physiological Society Coffee with Expert this week! Join for tips on navigating career decisions. Ideal for undergrads, grads & postdocs. Spread the word & Register at mophys.org/trainee #GradLife #STEMCareers #Careertips #PhDLife #IndustryCareers




